FELTON, California, March 5, 2018 /PRNewswire/ --
The global medical morphine market is expected to reachUSD 13.32 billion by 2024, driven by increasing morphine consumption in the U.S. The increasing prevalence of arthritis and cancer in geriatric patients is projected to impact the morphine market globally positively.
In terms of route of administration, the oral segment is expected to grow at the fastest CAGR over the projected period owing to its dose accuracy, high accessibility, and ease of carrying compared to injectables and other counterparts.
On the basis of indication, others segment is expected to grow at the fastest CAGR of 3.1% over the forecast period owing to increasing number of prescriptions of morphine in U.S. for nominal conditions. The cancer segment is expected to exhibit lucrative growth due to increasing prevalence of bone cancer globally.
Browse full research report with TOC on "Medical Morphine Market Size and Forecast, By Route of Administration (Oral, Injectable), By Indication (Cancer, Arthritis) And Trend Analysis, 2014 - 2024" at: https://www.hexaresearch.com/research-report/medical-morphine-market
Morphine with its use in therapeutics is also one of the most abused drug globally. Respective governments are introducing initiatives to prevent substance abuse and decrease death rates caused by morphine. Furthermore, researchers are concentrating on drug abuse treatment for opioid addicts which is expected to reduce the illicit use of morphine. For instance, in August 2017, researchers at University of California San Diego in collaboration with CARI therapeutics commenced development of a biosensor capable of detecting opioids in human bodies.
Browse reports of similar category by Hexa Research:
Hexa Research has segmented the global medical morphine market report based on route of administration, indication and region:
Segmentation by Route of Administration, 2014 - 2024 (USD Million)
Segmentation by Indication, 2014 - 2024 (USD Million)
Segmentation by Region, 2014 - 2024 (USD Million)
Rest of the World
Key players analyzed:
Purdue Pharma L.P.
Johnson Matthey Fine Chemicals
Sun Pharmaceutical Industries Ltd.
Verve Health Care Ltd.
Taj Pharmaceuticals Limited
MANUS AKTTEVA BIOPHARMA LLP
About Hexa Research
Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.
Contact: Michelle T. Corporate Sales Specialist Hexa Research Phone: +1-415-349-0058 Toll Free: 1-800-489-3075 Email: firstname.lastname@example.org
SOURCE Hexa Research
Subscribe to our Free Newsletters!
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...
Bronchopulmonary dysplasia or chronic lung disease of infancy is seen in premature and low birth ...View All